{
    "clinical_study": {
        "@rank": "122533", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "7 weekly/biweekly injections of a placebo buffer"
            }, 
            {
                "arm_group_label": "CYT003 low dose", 
                "arm_group_type": "Experimental", 
                "description": "7 weekly/biweekly injections of CYT003 low dose"
            }, 
            {
                "arm_group_label": "CYT003 medium dose", 
                "arm_group_type": "Experimental", 
                "description": "7 weekly/biweekly injections of CYT003 medium dose"
            }, 
            {
                "arm_group_label": "CYT003 high dose", 
                "arm_group_type": "Experimental", 
                "description": "7 weekly/biweekly injections of CYT003 high dose"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the therapeutic potential and safety/tolerability of\n      study drug (CYT003) at 3 dose levels versus placebo in patients with persistent moderate to\n      severe allergic asthma not sufficiently controlled on current standard controller therapy.\n\n      Altogether 360 patients randomized to 4 treatment groups will be included. The study\n      compares three dose strength with placebo. Each patient receives 7 injections of study drug\n      or undistinguishable placebo. Key outcome measures are patient reported parameters on their\n      asthma."
        }, 
        "brief_title": "CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Actual"
        }, 
        "condition": "Moderate to Severe Allergic Asthma", 
        "condition_browse": {
            "mesh_term": "Asthma"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Able and willing to provide written informed consent\n\n          -  Able and willing to complete all protocol requirements\n\n          -  Between 18 to 65 years of age\n\n          -  Presence of persistent asthma for at least 6 months according to GINA 2011 guidelines\n             at step 3 or 4 of treatment who has been on stable controller therapy for at least 4\n             weeks, and symptoms are not sufficiently controlled with medium to high doses of\n             inhaled corticosteroid (ICS) (>250 to \u22641000 \u00b5g/day fluticasone or equivalent) in\n             combination with or without long acting beta agonist (LABA), insufficient control\n             will be based on asthma control questionnaire (ACQ) score \u22651.5 points. Use of stable\n             doses of other controller therapies according to GINA steps 3 and 4 (leukotriene\n             modifiers, sustained release theophylline) are also acceptable, but NOT treatment\n             with anti immunoglobulin E (IgE) antibodies within the past 6 months\n\n          -  Stable but insufficiently controlled baseline conditions as documented by ACQ \u22651.5 at\n             the screening and the baseline visits.\n\n          -  Positive skin prick test (SPT) or radioallergosorbent test (RAST) to at least 1\n             aero-allergen during the screening period\n\n          -  Forced expiratory volume in one second (FEV1)\u226540 to \u226490% of predicted value\n\n          -  Reversibility of airway obstruction as demonstrated by:\n\n               -  FEV1 improvement by  >12% , and\n\n               -  By \u2265200 mL after inhaled \u03b22-agonist (400 \u00b5g salbutamol or equivalent). If a\n                  subject does not meet reversibility criteria at the screening visit,\n                  reversibility may be retested once prior to run-in as long as the test is\n                  performed at least 5 days prior to the beginning of the run-in phase\n\n        Exclusion Criteria:\n\n          -  Failure to meet at least 80% compliance with completion of asthma symptoms and\n             medication diaries at the baseline visit, after initial instruction at the screening\n             visit and where necessary additional training at the 2-weeks run-in visit. . An\n             additional maximum 2-weeks training period may be added in such patients.\n\n          -  Treatment or hospitalization for asthma exacerbation within past 2 months.\n\n          -  Current use or use of systemic corticosteroids within past 2 months.\n\n          -  Current smokers.\n\n          -  Ex-smokers with a smoking history of >10 pack years (1 package per day for 10 years).\n\n          -  Pregnancy or female planning to become pregnant during the study period.\n\n          -  Ongoing or planned specific immunotherapy (SIT) during the whole study period or SIT\n             completed within the last 3 years.\n\n          -  Treatment with IgE antibodies (Xolair\u00ae) within past 6 months.\n\n          -  Use of investigational unapproved drugs within 30 days or within 5 half-lives of the\n             investigational drug, whichever is longer, or planned use during the whole study\n             period.\n\n          -  Use of investigational biologics within the last 6 months.\n\n          -  Previous participation in a clinical study with a virus like particle (VLP) Qb-based\n             vaccine.\n\n          -  Possible dependency of the patient on sponsor and/or investigator.\n\n          -  Women of child bearing potential"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "365", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01673672", 
            "org_study_id": "CYT003-QbG10 12", 
            "secondary_id": "2012-003070-39"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "CYT003 low dose", 
                    "CYT003 medium dose", 
                    "CYT003 high dose"
                ], 
                "description": "7 subcutaneous injections, weekly/biweekly within 10 weeks", 
                "intervention_name": "CYT003", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "7 subcutaneous injections, weekly/biweekly within 10 weeks", 
                "intervention_name": "Placebo", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 13, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles, Huntington Beach, San Jose", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Walnut Creek, San Diego, Riverside, Fountain Valley", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Colorado Springs, Denver", 
                        "country": "United States", 
                        "state": "Colorado"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Waterbury", 
                        "country": "United States", 
                        "state": "Connecticut"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami, Tallahassee", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albany", 
                        "country": "United States", 
                        "state": "Georgia"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "South Bend", 
                        "country": "United States", 
                        "state": "Indiana"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Metairie", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bangor", 
                        "country": "United States", 
                        "state": "Maine"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bethesda", 
                        "country": "United States", 
                        "state": "Maryland"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "North Dartmouth", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ohmaha, Bellevue", 
                        "country": "United States", 
                        "state": "Nebraska"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Eugene, Medford", 
                        "country": "United States", 
                        "state": "Oregon"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Providence, Warwick", 
                        "country": "United States", 
                        "state": "Rhode Island"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Spartanburg, Summerville", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kyjov", 
                        "country": "Czech Republic"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Olomouc, Praha, Tabor, Ostrava, Hradec Kralove, Plzen, Brno", 
                        "country": "Czech Republic"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bad Woerishofen, Leipzig, Magdeburg", 
                        "country": "Germany"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Frankfurt aM, Delitzsch, Bonn, Berlin, Ruedersdorf", 
                        "country": "Germany"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Szazhalombatta, Komaron", 
                        "country": "Hungary"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tatabanya, Szombathely, Csorna, Budapest, Balassagyarmat", 
                        "country": "Hungary"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Haifa, Zerifin", 
                        "country": "Israel"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rehovot, Petach Tikva, Ramat Gan, Jerusalem, Ashkelon, Afula", 
                        "country": "Israel"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Slupsk, Lodz, Tarnow, Pila, Poznan, Wroclaw", 
                        "country": "Poland"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ekaterinburg", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tomsk,St.Petersburg,Yaroslavl,Novosibirsk,Smolensk,Barnaul", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Donetsk, Kharkiv, Kiew, Chernivtsi, Zaporizhzhya, Mykolayiv", 
                        "country": "Ukraine"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vinnytsya, Ivano-Frankivsk", 
                        "country": "Ukraine"
                    }, 
                    "name": "Cytos Investigator Sites"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Czech Republic", 
                "Germany", 
                "Hungary", 
                "Israel", 
                "Poland", 
                "Russian Federation", 
                "Ukraine"
            ]
        }, 
        "number_of_arms": "4", 
        "official_title": "A Randomized, Placebo-Controlled, Phase IIb Dose-Finding Study of CYT003-QbG10, a TLR9-Agonist, in Patients With Moderate to Severe Allergic Asthma Not Sufficiently Controlled on Current Standard Therapy (GINA Steps 3+4)", 
        "overall_official": {
            "affiliation": "Creighton University, Omaha (NE)", 
            "last_name": "Thomas B Casale, Professor", 
            "role": "Study Chair"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Germany: Paul-Ehrlich-Institut"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Asthma Control Questionnaire", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01673672"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Cytos Biotechnology AG", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cytos Biotechnology AG", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014", 
        "why_stopped": "primary endpoint missed"
    }
}